跳到主要內容

Herbert Timothy P. 的 Form 4/A 修正申報

修正

Inspire Medical Systems, Inc.(INSP),2023/3/13 申報

申報編號
0001104659-23-031817
申報時間
2023/3/13
交易日
2022/3/29
申報延遲
349 天
10b5-1 計畫
表單沒有這欄(2023 年以前)
原始申報日
2022/3/29

這份申報列了 4 筆非衍生性交易。沿用原件裡沒有重述的 6 筆交易。公開市場賣出合計 $2,932 萬。交易後 349 天申報。

這份修正申報重述了 0001104659-22-039633(2022/3/29 申報)的一部分,沒有重述的交易仍然有效,列在下面。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Herbert Timothy P.CIK 0001737136董事、高階主管(執行長、總裁)

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2022/3/29Common StockS賣出處分−74,315$250.20F2−$18,593,61340,990間接
2022/3/29Common StockS賣出處分−13,619$251.06F5−$3,419,186.14105,123間接
2022/3/29Common StockS賣出處分−1,465$251.92F8−$369,062.8103,658間接
2022/3/29Common StockS賣出處分−8,017$252.39F9−$2,023,410.63106,773直接

沿用原件的交易

這份修正申報只重述了原件的一部分。原件其他的交易仍然有效,網站的交易表把它們算在這份修正申報底下。

來自 0001104659-22-039633(2022/3/29 申報)。

非衍生性證券(表 I)

沿用 0001104659-22-039633 的非衍生性證券交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2022/3/25Common StockS賣出處分−695$250.00−$173,750120,455直接
2022/3/28Common StockS賣出處分−1,546$250.00F2−$386,500118,909直接
2022/3/25Common StockS賣出處分−42$250.00−$10,500122,833間接
2022/3/28Common StockS賣出處分−2,542$250.00F7−$635,500120,291間接
2022/3/29Common StockS賣出處分−6,280$251.41F9−$1,578,854.831,302間接
2022/3/29Common StockS賣出處分−8,427$252.37F10−$2,126,721.9922,875間接

原件的附註

這幾筆交易的價格在原件上引用的附註。

F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.00 to $250.01. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F7

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.00 to $250.01. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F9

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.01 to $251.85. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F10

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.095 to $252.935. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F1

This Form 4 amends and restates the previously reported sale transactions made by the Margaret C. Herbert 2018 Family Irrevocable GST Trust that occurred on March 29, 2022 in order to re-allocate such sales between three different sellers that are considered beneficially owned by the Reporting Person.

F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.00 to $250.78. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F3

The amount of securities listed in Column 5 reflects the total shares held following the transaction owned by the Margaret C. Herbert 2018 Family Irrevocable GST Trust, by reference to the total reported in the Reporting Person's Form 4 filed on March 13, 2023. The total has increased from such Form 4 as a result of the prior overstatement of the sales by such trust on March 29, 2022 by 23,101 shares, which is corrected herein.

F4

Shares held by the Margaret C. Herbert 2018 Family Irrevocable GST Trust.

F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.78 to $251.77. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F6

The amount of securities listed in Column 5 reflects the total shares held following the transaction based on reference to the total reported in the Reporting Person's Form 4/A related to transactions originally reported on March 21, 2022 and that was filed on March 13, 2023.

F7

Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust.

F8

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.85 to $252.10. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F9

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.10 to $252.935. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)